Trade Mark Journal No.2026/012 20 March 2026

UK00004348293 3 March 2026 (5,36,42)

LITE STRATEGY

International priority date claimed: 5 September 2025 (Mauritius) (MU/M/2025/42324)
Class 5
Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders.
Class 36
Financial services; financial services, namely, providing cryptocurrency treasury reserve services; investment of funds for others in the field of cryptocurrency and cryptocurrency mining; financial management services and financial advisory services in the fields of cryptocurrency and cryptocurrency mining.
Class 42
Pharmaceutical research and development.

Lite Strategy, Inc.

Representative: Morgan, Lewis & Bockius UK LLP